News
In the current issue of Circulation, Mehta and colleagues compared 1-year saphenous vein graft failure (defined as ≥75% angiographic stenosis or occlusion) and 5-year clinical events (composite of ...
Crews went through a manhole to rescue a woman who was found trapped in a storm drain in Southern California several days after she was reported missing, officials said. Yafang Zhou, 59 ...
BELLA trial evaluates relacorilant, nab-paclitaxel, and Avastin in platinum-resistant ovarian cancer patients across multiple regions. Phase 3 ROSELLA trial showed relacorilant improved ...
The development of antibody-drug conjugates (ADCs) remains a central theme in ongoing research within the realm of ovarian cancer, and work examining different targets and sequencing considerations ...
Allegations that Ascension Parish crews did drainage ditch work along a private road have led to the firing of two government employees — with one council member calling the sequence of events ...
SAN JUAN, Puerto Rico — The Dutch Caribbean territory of St. Maarten is offering cash, plane tickets and an extended hotel stay to attract professionals and students back home.
The mediolateral diameter of the falcine sinus (FS) on fetal magnetic resonance imaging is a robust predictor of aggressive neonatal presentation requiring early treatment in vein of Galen ...
LUBBOCK, Texas — The City of Lubbock has charged a storm drain water fee residentially and commercially since the early 2000s. According to Sarah Mendoza-Urrutia, a Stormwater Plan Analyst with ...
A new drug is showing promise in tackling treatment-resistant ovarian cancer. Relacorilant, the drug tested in a phase 3 ROSELLA trial with Corcept Therapeutics in California, was found to improve ...
Many countries have tried to emulate this model of science-led growth, and to stop the ‘brain drain’ of talent to better-resourced laboratories in the United States. Now, the actions of the US ...
namely the Superficial middle cerebral vein (SMCA), Vein of Labbe (VOL), and Sphenoparietal sinus (SPS), which can basically cover the venous drainage of the entire MCA region. This means that COVES ...
Results from Corcept’s Phase 2 trial of relacorilant in patients with platinum-resistant ovarian cancer were published in the Journal of Clinical Oncology in June 2023. The ROSELLA trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results